
Piprasafe T 4000mg/500mg Injection
Marketer
Safecon Lifesciences
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Piprasafe T 4000mg/500mg Injection
T-Pipra 4000mg/500mg injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, the dosage and frequency are determined by your physician based on your condition's severity; strict adherence to prescribed usage is crucial. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects warrant immediate medical consultation. Prior to use, disclose any antibiotic allergies, liver, or kidney issues to your doctor; adjustments to dosage or alternative medication may be necessary. Under medical guidance, this medication is generally considered safe for pregnant and breastfeeding individuals.
Uses of Piprasafe T 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Piprasafe T 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Piprasafe T 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Piprasafe T 4000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Piprasafe T 4000mg/500mg Injection works:
The injectable formulation Piprasafe T (4000mg piperacillin/500mg tazobactam) unites two active agents. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Piprasafe T 4000mg/500mg Injection's concurrent use with alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Piprasafe T (4000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Piprasafe T (4000mg/500mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Piprasafe T 4000mg/500mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Piprasafe T 4000mg/500mg Injection with care; dosage modifications may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Piprasafe T 4000mg/500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Piprasafe T 4000mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Piprasafe T 4000mg/500mg Injection, seek advice from your physician.
Facts to Know About Piprasafe T 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
